Back to CLDX

SILVERARC CAPITAL MANAGEMENT, LLC → CLDX

SILVERARC CAPITAL MANAGEMENT, LLC CLDX Position History

Celldex Therapeutics, Inc.

Quarters held
3
Latest value
$15.8M
Q3 2026
Peak value
$15.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$5.2M
Q1 2026$5.7M
Q3 2026$15.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$15.8M487.6K——
Q1 2026$5.7M178.4K——
Q4 2025$5.2M191.1K——

Other funds holding CLDX

Other SILVERARC CAPITAL MANAGEMENT, LLC positions

KOD

KODIAK SCIENCES INC

$71.1M
CELC

CELCUITY INC

$63.9M
KALU

KALVISTA PHARMACEUTICALS INC

$57.9M
AAVXF

ABIVAX SA

$56.9M
ASND

ASCENDIS PHARMA A/S

$55M
DNTH

DIANTHUS THERAPEUTICS INC

$54.9M
CELC

CELCUITY INC

$52.4M
COGT

COGENT BIOSCIENCES INC

$50.6M